· Investment Management
OrbiMed's Asian fund crosses the billion-dollar line
The healthcare investor has raised USD 3 billion across two new funds.

OrbiMed has raised USD 3 billion in commitments across two healthcare funds. Private Investments X has more than USD 1.9 billion for life sciences venture investments in the US and Europe. Asia Partners VI has over USD 1 billion for Asian venture and growth investments, up from USD 751 million for its predecessor. Both funds cover areas including drugs, medical devices and diagnostics. Founded in New York in 1989, OrbiMed launched its first dedicated venture capital fund in 2000.

